← Back to Clinical Trials
Recruiting NCT05685628

NCT05685628 Evaluation of the Quality of Life Induced by the Cinnamon Anti-odor Dressing in Patients With Malodorous Wounds

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05685628
Status Recruiting
Phase
Sponsor Assistance Publique - Hôpitaux de Paris
Condition Malodorous Wounds (Chronic, Malignant or Infected Wounds)
Study Type INTERVENTIONAL
Enrollment 98 participants
Start Date 2023-10-04
Primary Completion 2027-04-19

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Cinnamon dressingCharcoal dressing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 98 participants in total. It began in 2023-10-04 with a primary completion date of 2027-04-19.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Refer to "Detailed description".

Eligibility Criteria

Inclusion Criteria: * Patient \>18 years of age with a smelly wound (discomfort \> 4/10 expressed by the patient); * Predictive wound healing \>14 days (clinical judgement); * Patient benefiting from a social security scheme (AME excluded) * Patient, and curator if applicable, informed and having signed the consent form for participation in the study Exclusion Criteria: * Patient who has received a secondary charcoal or cinnamon dressing within the last 48 hours * Patient with pressure ulcer stage 1 or 2 * Patient treated by metronidazole or antimicrobial for \< 3 days; * Patient who cannot communicate his feelings; * Anosmic patient; * Patient with cinnamon allergy; * Persons deprived of their liberty or under guardianship; * Inability to submit to the medical follow-up of the trial for geographical, social, psychological or cognitive reasons.

Contact & Investigator

Central Contact

Maxime CHERON, IDE

✉ maxime.cheron@curie.fr

📞 01 44 32 42 34

Principal Investigator

Isabelle FROMANTIN, IDE

STUDY DIRECTOR

Institut Curie

Frequently Asked Questions

Who can join the NCT05685628 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Malodorous Wounds (Chronic, Malignant or Infected Wounds). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05685628 currently recruiting?

Yes, NCT05685628 is actively recruiting participants. Contact the research team at maxime.cheron@curie.fr for enrollment information.

Where is the NCT05685628 trial being conducted?

This trial is being conducted at Vaux-le-Pénil, France, Créteil, France, Créteil, France, Levallois-Perret, France and 3 additional locations.

Who is sponsoring the NCT05685628 clinical trial?

NCT05685628 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Isabelle FROMANTIN, IDE at Institut Curie. The trial plans to enroll 98 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology